Patel Mahesh V. 4
4 · Lipocine Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Patel Mahesh V.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-18$4.20/sh+8,629$36,242→ 157,668 totalExercise: $4.20From: 2026-12-18Exp: 2035-12-18→ Common Stock (8,629 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 18, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.